Shaun Carter
Profile
Shaun Carter worked as a Group Development & Strategy Director at Intersect ENT, Inc. and as a Director-Group Development & Strategy at Carillion Plc.
He holds an MBA from Warwick Business School.
Former positions of Shaun Carter
| Companies | Position | End |
|---|---|---|
| CARILLION PLC | Corporate Officer/Principal | 2017-12-30 |
| INTERSECT ENT, INC. | Corporate Officer/Principal | - |
Training of Shaun Carter
| Warwick Business School | Masters Business Admin |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| CARILLION PLC | Industrial Services |
| Private companies | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Stock Market
- Insiders
- Shaun Carter